Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
about
Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectivesPlasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemiaRelation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.Prevalence of Hepatitis C among Multi-transfused Thalassaemic Patients in Oman: Single centre experience.Treating thalassemia major-related iron overload: the role of deferiprone.Beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects.Development and Validation of a Multidimensional Expectation Questionnaire for Thalassaemia Major Patients.Coronary atherosclerosis burden is not advanced in patients with β-thalassemia despite premature extracardiac atherosclerosis: a coronary artery calcium score and carotid intima-media thickness study.MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.Malignancies in beta-thalassemia patients: a single-center experience and a concise review of the literature.The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study.Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.Iron-chelating therapies in a transfusion-dependent thalassaemia population in Thailand: a cost-effectiveness study.Deferasirox: pharmacokinetics and clinical experience.Increasing prevalence of thalassemia in America: Implications for primary care.Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients.Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.Immunoglobulin levels and CD4 / CD8 counts in β- thalassemia major.Determination of hepatitis C genotypes and the viral titer distribution in children and adolescents with major thalassemia.In search of the optimal iron chelation therapy for patients with thalassemia major.Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.Sustained ventricular tachycardia in a patient with thalassemia majorCardiac mortality in {beta}-thalassemia major: resting but not dobutamine stress echocardiography predicts mortality among initially cardiac disease-free patients in a prospective 12-year study.A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.Early impairment of myocardial function in young patients with beta-thalassemia major.Trends in 5-, 10-, 20-, and 30-year survival rates of beta-thalassemia patients in Southern Iran, 1995-2016: A retrospective cohort study.Apolipoprotein E Polymorphism and Left Ventricular Failure in Beta-Thalassemia: A Multivariate Meta-Analysis.Are people getting quality thalassemia care in twin cities of Pakistan? A comparison with international standards.Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo.Clinical Features of β-Thalassemia and Sickle Cell Disease.Hepatitis C in patients with β-thalassemia major. A single-centre experience.Quantitative ultrashort echo time imaging for assessment of massive iron overload at 1.5 and 3 Tesla.Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.Heart Rate Variability for Early Detection of Iron Overload Cardiomyopathy in β-Thalassemia Patients.Survival analysis of thalassemia major patients using Cox, Gompertz proportional hazard and Weibull accelerated failure time models.Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
P2860
Q26740347-651CB364-841E-4C31-B681-C6B1AD7F87E1Q34188093-46EF7848-EC2A-4625-B7A1-6E3737016728Q34269245-1451BB8D-1D75-44B1-8A8B-3EB35A369E48Q35054058-26631C53-A845-4CE7-A7CE-BC3B368A7640Q36344669-056097E7-FFC4-469B-8A54-257D55B906E2Q36555894-D2A31F2F-2AA9-4DC3-9DE2-861EAFB13E64Q36718841-D944B721-5CCA-4920-9414-23E776610CA4Q36863932-5FD613BC-0553-45A9-9F7B-01FDFA330C83Q36915101-17D16045-1A68-4A08-9506-6B151FD878A7Q37107477-7380FF32-BBFC-4F17-B623-4A7BACD0B112Q37268421-F55F2296-63D2-442F-B349-BEC0806493BEQ37859718-64F99AF9-21CB-4790-BAED-EACE5E82B0FEQ37882681-89FF6D2E-7EBD-4A8A-BDFB-615C7118B356Q37969225-8C4D0D20-4787-438A-A5EA-CF35C3D6D8D6Q38626123-AF5A9CED-C99B-4575-96FE-EC3129390F7EQ38937817-D04BABFC-707F-442F-BC0A-D83E07CE4233Q41562000-CCD06F36-14AB-4293-8CF2-74BE8F9788B8Q41562709-F6E6C9D6-3304-4E53-958F-AFBB22A203C5Q41835172-F0AB82C1-7064-40B0-9712-AD6A5A6F4DBDQ42558429-26079C5F-F62D-46CD-ACC3-85987E191B5EQ42588946-AFCEEF2D-F9EC-421E-B767-ECB1F3DBDF0FQ42720485-B53A8BF6-9ECA-4B48-9E01-11DD783570ABQ43248482-CD559920-293A-4806-AA63-563393A0822EQ45820695-89E5BDF6-B8E6-4A5F-9036-9BB2AA5903E2Q46745560-E906BC96-1346-45F6-8D2A-47312FBA0F5AQ47137705-205C606E-6963-4CB9-A429-F34DDB2604BCQ48188438-A271B49D-830B-4AF2-BAFF-6C97C12676E1Q48515785-A5718737-7138-4471-AA0A-518B54BB49D4Q50003300-8382DF1E-9398-43DF-866B-FD55B9D80BC6Q50061141-398E8A8C-DEFD-441F-ACE6-D5DD870FDFE0Q50871363-2A837C07-3022-470A-8AA7-092FAE67B214Q50951880-2F31A683-0E40-42EF-9641-1FD899567FBCQ52575650-C71EEB74-3039-443B-AD6F-FAEA21FEB55FQ53483905-E124EDFA-1318-4CAB-BD12-4A333205AA34Q55363217-EE546342-05E5-459A-B9F4-EA5DC34EA0C3Q58769184-1F56B2C0-CA3D-4B90-B0D9-65A2736F062A
P2860
Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Longitudinal study of survival ...... h thalassemia major in Greece.
@en
type
label
Longitudinal study of survival ...... h thalassemia major in Greece.
@en
prefLabel
Longitudinal study of survival ...... h thalassemia major in Greece.
@en
P2093
P356
P1476
Longitudinal study of survival ...... h thalassemia major in Greece.
@en
P2093
Christos Kattamis
Emmanuel Kanavakis
George Chouliaras
Helen Berdousi
Vassilis Ladis
P304
P356
10.1196/ANNALS.1345.067
P407
P577
2005-01-01T00:00:00Z